Kagocel powder instructions for use. How to take Kagocel for adults

Tablets - 1 tablet:

Active substance: Kagocel® 12 mg;
Excipients: potato starch - 10 mg, calcium stearate - 0.65 mg, Ludipress (composition: lactose monohydrate, povidone (Kollidon 30), crospovidone (Kollidon CL)) - to obtain a tablet weighing 100 mg.

Tablets, 12 mg.

10 tablets per blister pack made of polyvinyl chloride/polyvinylidene chloride film and aluminum foil with a heat-sealable coating.

1, 2 or 3 strip strips along with instructions for use are placed in a pack.

Description of the dosage form

Tablets from white with a brownish tint to light brown, round, biconvex, interspersed with brown.

Pharmacological action

Kagocel is a highly effective new generation antiviral drug.

Pharmacokinetics

24 hours after administration to the body, Kagocel® accumulates mainly in the liver, and to a lesser extent in the lungs, thymus, spleen, kidneys, and lymph nodes. Low concentrations are observed in adipose tissue, heart, muscles, testes, brain, and blood plasma. The low content of Kagocel® in the brain is explained by the high molecular weight of the drug, which makes it difficult to penetrate the blood-brain barrier. In the blood plasma the drug is found predominantly in bound form.

With daily repeated administration of Kagocel®, the volume of distribution varies widely in all organs studied. The accumulation of the drug is especially pronounced in the spleen and lymph nodes. When taken orally, about 20% of the administered dose of the drug enters the general bloodstream. The absorbed drug circulates in the blood, mainly in the form associated with macromolecules: with lipids - 47%, with proteins - 37%. The unbound portion of the drug is about 16%.

Excretion: the drug is excreted from the body mainly through the intestines: 7 days after administration, 88% of the administered dose is excreted from the body, including 90% through the intestines and 10% through the kidneys. The drug was not detected in exhaled air.

Pharmacodynamics

The main mechanism of action of Kagocel® is the ability to induce the production of interferons. Kagocel® causes the formation in the human body of so-called late interferons, which are a mixture of α- and β-interferons with high antiviral activity. Kagocel® causes the production of interferons in almost all cell populations involved in the body's antiviral response: T- and B-lymphocytes, macrophages, granulocytes, fibroblasts, endothelial cells. When one dose of Kagocel® is taken orally, the interferon titer in the blood serum reaches its maximum values after 48 hours. The body's interferon response to Kagocel® administration is characterized by prolonged (up to 4-5 days) circulation of interferons in the bloodstream. The dynamics of interferon accumulation in the intestine when Kagocel® is taken orally does not coincide with the dynamics of circulating interferon titers. In the blood serum, the production of interferons reaches high values only 48 hours after taking Kagocel®, while in the intestine the maximum production of interferons is observed after 4 hours.

Kagocel®, when prescribed in therapeutic doses, is non-toxic and does not accumulate in the body. The drug does not have mutagenic or teratogenic properties, is not carcinogenic and does not have embryotoxic effects.

The greatest effectiveness in treatment with Kagocel® is achieved when it is prescribed no later than the 4th day from the onset of acute infection. For preventive purposes, the drug can be used at any time, including immediately after contact with the infectious agent.

Instructions

Inside, regardless of food intake.

For the treatment of influenza and ARVI, adults are prescribed 2 tablets 3 times a day in the first two days, and one tablet 3 times a day in the next two days. A total of 18 tablets per course, course duration – 4 days.

Prevention of influenza and ARVI in adults is carried out in 7-day cycles: two days - 2 tablets once a day, 5 days break, then repeat the cycle. The duration of the preventive course is from one week to several months.

For the treatment of herpes in adults, 2 tablets are prescribed 3 times a day for 5 days. A total of 30 tablets per course, course duration – 5 days.

For the treatment of influenza and ARVI, children aged 3 to 6 years are prescribed in the first two days - 1 tablet 2 times a day, in the next two days - one tablet 1 time a day. A total of 6 tablets per course, course duration – 4 days.

For the treatment of influenza and acute respiratory viral infections, children over 6 years of age are prescribed 1 tablet 3 times a day in the first two days, and one tablet 2 times a day in the next two days. A total of 10 tablets per course, course duration – 4 days.

Prevention of influenza and ARVI in children aged 3 years and older is carried out in 7-day cycles: two days - 1 tablet once a day, 5 days break, then repeat the cycle. The duration of the preventive course is from one week to several months.

Indications for use Kagocel

Kagocel® is used in adults and children over the age of 3 years as a preventive and therapeutic agent for influenza and other acute respiratory viral infections (ARVI), as well as a therapeutic agent for herpes in adults.

Contraindications to the use of Kagocel

Pregnancy and lactation;
Age up to 3 years;
Hypersensitivity to the components of the drug;
Lactase deficiency, lactose intolerance, glucose-galactose malabsorption.

Kagocel Use during pregnancy and children

Due to the lack of necessary clinical data, Kagocel® is not recommended for use during pregnancy and lactation.

Kagocel Side effects

Allergic reactions may develop.

If any of the side effects indicated in the instructions get worse, or you notice any other side effects not listed in the instructions, tell your doctor.

Drug interactions

Kagocel® combines well with other antiviral drugs, immunomodulators and antibiotics (additive effect).

Dosage Kagocel

Inside. For the treatment of influenza and ARVI, adults are prescribed 2 tablets. 3 times a day in the first 2 days, in the next 2 days - 1 tablet. 3 times a day. A total of 18 tablets per course of treatment, course duration - 4 days.

Prevention of respiratory viral infections in adults is carried out in 7-day cycles: 2 days, 2 tablets. Once a day, then a break for 5 days and the cycle is repeated. The duration of the preventive course is from 1 week to several months. For the treatment of herpes, adults are prescribed 2 tablets. 3 times a day for 5 days.

A total of 30 tablets per course of treatment, course duration - 5 days. For the treatment of influenza and acute respiratory viral infections, children over 6 years of age are prescribed 1 tablet. 3 times a day in the first 2 days, in the next 2 days - 1 tablet. 2 times a day. A total of 10 tablets per course of treatment, course duration - 4 days.

Overdose

Precautions

To achieve a therapeutic effect, Kagocel® should be taken no later than the fourth day from the onset of the disease.

Impact on the ability to drive vehicles and operate machinery

The effect of the drug on the ability to drive vehicles and operate machinery has not been studied.

Kagocel: instructions for use and reviews

Kagocel is an immunomodulatory and antiviral drug.

Release form and composition

Kagocel is produced in the form of tablets: round, biconvex, brown to cream in color with inclusions (10 pieces in strip packs, 1 pack in a cardboard box).

1 tablet contains:

Active substance: kagocel – 12 mg;
Auxiliary components: calcium stearate - 0.65 mg, potato starch - 10 mg, ludipress (directly compressed lactose with the composition: lactose monohydrate, Kollidon 30 (povidone), Kollidon CL (crospovidone)) - to obtain a tablet weighing 100 mg.

Pharmacological properties

Pharmacodynamics

Kagocel induces the production of late interferons (a mixture of α- and β-interferons), which have high antiviral activity. Kagocel stimulates the production of interferons in cell populations that form the body's antiviral response: macrophages, T-, B-lymphocytes, granulocytes, endothelial cells, fibroblasts. When taking one dose of Kagocel orally, the maximum values of the interferon titer in the blood serum are achieved after 2 days. The body's interferon response is characterized by prolonged (4–5 days) circulation of interferons in the bloodstream. When Kagocel is taken orally, the dynamics of circulating interferon titers does not correspond to the dynamics of interferon accumulation in the intestine. In the intestine, the maximum production of interferons is achieved after 4 hours, and the production of interferons in the blood serum reaches high values 2 days after taking Kagocel.

When prescribed in therapeutic doses, the drug is non-toxic and does not accumulate in the body. Does not have teratogenic, mutagenic properties and embryotoxic effects, and is not carcinogenic.

When treating with Kagocel, the greatest effectiveness is ensured when the drug is prescribed no later than the fourth day from the onset of acute infection. Kagocel can be used for preventive purposes at any time, including immediately after interaction with an infectious agent.

Pharmacokinetics

One day after taking Kagocel, it accumulates mainly in the liver, and also to a lesser extent in the thymus, lungs, kidneys, lymph nodes, and spleen. Low concentrations are observed in the heart, adipose tissue, testes, muscles, blood plasma, and brain. The low content of the active substance in the brain is observed due to the high molecular weight, which makes it difficult to penetrate the blood-brain barrier. The drug is found predominantly in bound form in the blood plasma.

In the case of daily repeated administration, the volume of distribution of Kagocel in the studied organs varies widely. The accumulation of the drug is especially pronounced in the lymph nodes and spleen. When administered orally, approximately 20% of the administered dose is present in the general bloodstream. The drug circulates in the blood mainly in the form associated with macromolecules: 47% with lipids, 37% with proteins. About 16% is the unbound portion of the drug.

Kagocel is excreted from the body primarily through the intestines. After 7 days, 88% of the dose is excreted, of which 90% is excreted through the intestines and 10% by the kidneys. Not detected in exhaled air.

Indications for use

Influenza and other acute respiratory viral infections (treatment and prevention in adults and children over 3 years old);
Herpes (treatment in adults).

Contraindications

Lactose intolerance, lactase deficiency, glucose-galactose malabsorption;
Age up to 3 years;
Pregnancy and lactation (breastfeeding);
Hypersensitivity to the components of the drug.

Instructions for use of Kagocel: method and dosage

Kagocel is taken orally.

For adults, the drug is prescribed depending on the indications:

Treatment of acute respiratory viral infections (ARVI) and influenza: in the first 2 days of use – 3 times a day, 24 mg (2 tablets), in the next 2 days the single dose is reduced by 2 times (18 tablets per course in total);
Prevention of acute respiratory viral infections and influenza: 2 days of use - 24 mg once a day, then a break for 5 days. Cycles of 7 days can be repeated (the duration of the preventive course varies from 7 days to several months);
Treatment of herpes: 3 times a day, 24 mg for 5 days (a total of 30 tablets per course).

For the treatment of ARVI and influenza, children are prescribed:

3-6 years: in the first 2 days of use - 2 times a day, 12 mg (1 tablet), in the next 2 days - 1 time a day, 12 mg (total 6 tablets per course);
From 6 years: in the first 2 days of use – 3 times a day, 12 mg, in the next 2 days – 2 times a day, 12 mg (a total of 10 tablets per course);
For the prevention of ARVI and influenza, the drug should be taken in courses of 7 days for children: 2 days – 12 mg once a day, then a break for 5 days. Cycles of 7 days can be repeated (the duration of the preventive course varies from 7 days to several months).

Side effects

During the use of Kagocel, side effects may occur, manifested in the form of allergic reactions.

Before starting to use Kagocel, as well as in cases of development of uncharacteristic symptoms, you should consult a doctor.

Overdose

Special instructions

To achieve a therapeutic effect, it is recommended to start taking Kagocel no later than the fourth day from the onset of the disease.

According to the instructions, Kagocel combines well with antibiotics, immunomodulators and other antiviral drugs.

Use during pregnancy and lactation

It is prohibited to take the drug during pregnancy and breastfeeding, since there is no necessary clinical data on its safety for this category of patients.

Use in childhood

It is prohibited to use Kagocel to treat patients under 3 years of age.

Drug interactions

During simultaneous use of Kagocel with antibiotics, immunomodulators and other antiviral drugs, an additive effect is observed.

Analogues

Analogues of Kagocel are: Aveol, Aqua Maris, Bicyclol, Vazonat, Glyciram

Terms and conditions of storage

Store in a dry, dark place, out of reach of children, at temperatures up to 25°C.

Shelf life – 2 years.

The page contains instructions for use Kagotsela. It is available in various dosage forms of the drug (12 mg tablets), and also has a number of analogues. This abstract has been verified by experts. Leave your feedback on the use of Kagocel, which will help other site visitors. The drug is used for various diseases (treatment and prevention of influenza, ARVI, colds). The product has a number of side effects and interactions with other substances. Doses of the drug differ for adults and children. There are restrictions on the use of the medicine during pregnancy and breastfeeding. Treatment with Kagocel can only be prescribed by a qualified doctor. The duration of therapy may vary and depends on the specific disease.

Instructions for use and dosage

For adults

For the treatment of influenza and ARVI, it is prescribed in the first 2 days - 2 tablets 3 times a day, in the next 2 days - 1 tablet 3 times a day. A total of 18 tablets per course lasting 4 days.

Prevention of influenza and ARVI is carried out in 7-day cycles: 2 days - 2 tablets 1 time per day, break for 5 days. Then the cycle is repeated. The duration of the preventive course varies from 1 week to several months.

For the treatment of herpes, 2 tablets are prescribed 3 times a day for 5 days. A total of 30 tablets for a course lasting 5 days.

Children aged 6 years and older

For the treatment of influenza and ARVI, it is prescribed in the first 2 days - 1 tablet 3 times a day, in the next 2 days - 1 tablet 2 times a day. A total of 10 tablets per course lasting 4 days.

Prevention of influenza and ARVI is carried out in 7-day cycles: 2 days - 1 tablet once a day, a break for 5 days, then the cycle is repeated. The duration of the preventive course is from 1 week to several months.

Release forms

Tablets 12 mg. There is no specific pediatric form of the drug noted.

Kagocel- antiviral drug. Interferon synthesis inducer.

Causes the formation in the body of so-called late interferon, which is a mixture of alpha and beta interferons with high antiviral activity. Kagocel causes the production of interferon in almost all cell populations involved in the body's antiviral response: T- and B-lymphocytes, macrophages, granulocytes, fibroblasts, endothelial cells. When one dose of Kagocel is taken orally, the interferon titer in the blood serum reaches maximum values after 48 hours. The body's interferon response to the administration of Kagocel is characterized by prolonged (up to 4-5 days) circulation of interferon in the bloodstream. The dynamics of interferon accumulation in the intestine when taking the drug orally does not coincide with the dynamics of circulating interferon titers. In the blood serum, the interferon content reaches high values only 48 hours after taking the drug Kagocel, while in the intestine the maximum interferon production is observed after 4 hours.

The greatest effectiveness in treatment with Kagocel is achieved when it is prescribed no later than the 4th day from the onset of acute infection. For preventive purposes, the drug can be used at any time, incl. and immediately after contact with an infectious agent.

Pharmacokinetics

When taken orally, about 20% of the administered dose of the drug enters the general bloodstream. 24 hours after oral administration, the drug accumulates mainly in the liver, and to a lesser extent in the lungs, thymus, spleen, kidneys, and lymph nodes. Low concentrations are observed in adipose tissue, heart, muscles, testes, brain, and blood plasma. The low content in the brain is explained by the high molecular weight of the drug, which makes it difficult to penetrate the blood-brain barrier (BBB). It is excreted mainly through the intestines: 7 days after administration, 88% of the administered dose is excreted from the body, including 90% in feces and 10% in urine. The drug was not detected in exhaled air.

Indications

prevention and treatment of influenza and other acute respiratory viral infections in adults and children aged 6 years and older;
treatment of herpes in adults.

Contraindications

pregnancy;
children under 6 years of age;
increased individual sensitivity.

Special instructions

To achieve a therapeutic effect, taking Kagocel should begin no later than the 4th day from the onset of the disease.

Kagocel combines well with other antiviral drugs, immunomodulators and antibiotics.

Side effect

allergic reactions.

Drug interactions

With the simultaneous use of the drug Kagocel with other antiviral drugs, immunomodulators and antibiotics, an additive effect is observed (they enhance the effect of each other).

Analogues of the drug Kagocel

The drug Kagocel has no structural analogues for the active substance.

Use in children

Contraindicated in children under 6 years of age.

Use during pregnancy and breastfeeding

The drug is contraindicated for use during pregnancy and lactation (breastfeeding).

Kagocel, when prescribed in therapeutic doses, is non-toxic and does not accumulate in the body. The drug does not have mutagenic or teratogenic properties, is not carcinogenic and does not have embryotoxic effects.

It is always easier to prevent a disease than to deal with its consequences later. Only a person with strong immunity is able to resist viruses. Sometimes internal potential is reduced due to a number of factors: hypothermia, chronic diseases, surgical intervention, stressful conditions, etc.

During the cold season, many experts recommend taking interferon-based drugs that stimulate the immune system. Today, such medications can be purchased at any pharmacy without a doctor's prescription. Kagocel is considered one of the most effective drugs in this group. It has a powerful effect and is often used for the treatment and prevention of influenza and ARVI.

General information about the drug Kagocel

In the Russian Federation, the production of Kagocel began in 2003. The pharmaceutical company Nearmedic Plus has developed a unique drug that can be taken by both adults and children over three years of age. It is produced in tablet form. Cream tablets with small inclusions have a biconvex shape. The cardboard box contains one cellular blister with 10 tablets.

The drug contains a biologically active substance - kagocel, as well as potato starch, calcium stearate and other additional components. The active substance, combined with the cellulose base, is only half absorbed. Due to this, the rest of the medicine interacts with the immune system. Kagocel promotes the production of interferon in the body. This is not a quick process, it can take from 5 to 7 days, so the drug can be taken as a prophylactic during the cold season.

Kagocel is a publicly available over-the-counter drug, but you should not offer it to sick children every time. Cold medicine is effective only in specific situations, and parents cannot always distinguish the viral nature of the disease from the bacterial one.

Features of the drug

Within 24 hours from the start of taking the medicine, the active substance gradually accumulates in organs with pronounced immune properties against non-cellular infectious agents. A small amount of kagocel is concentrated in adipose tissue, heart, muscles, brain, etc. The level of interferon in the blood slowly increases (its maximum occurs on the 2nd day from the moment of taking the tablets). In the intestines, the maximum concentration of biologically active substances is achieved 4 hours after taking Kagocel.

The antiviral agent has a long-term therapeutic effect. The production of interferon and cytokines in response to a viral infection lasts 5 days. Patients taking Kagocel feel better after just 4 days.

The drug acts as an antiviral, antimicrobial and immunomodulatory agent, so some patients tend to classify it as an antibiotic. However, clinical pharmacology has a different opinion. Experts classify this medicine as a product of natural or semi-natural origin. Thanks to its amazing qualities, Kagocel for children has the right to be called one of the best anti-cold medicines, whose action is not aimed at fighting specific viruses, but at maintaining immunity.

When is Kagocel prescribed to children?

According to statistics, preschool children and primary school students are more likely to suffer from colds. On average, children get sick with acute respiratory infections 10 times a year. Frequent colds lead to decreased immunity. In turn, visiting preschool and school institutions leads to the child becoming infected again. To help a child adapt to a close group, many pediatricians recommend taking Kagocel.

The drug is prescribed for the treatment and prevention of:

Although the medicine helps to overcome the infection faster, this is not a reason to refuse other treatment methods. During therapy, you must follow all the doctor's recommendations. It is important to follow the dosage and not take Kagocel for more than 7 days.

Efficacy in the treatment of ARVI in children

According to the instructions for use, there is no point in taking the drug if the patient has already been sick for more than 4 days. The effect of taking Kagocel in this case will be minimal. It accumulates in the body for a long time, and active production of interferon occurs only 5–7 days after the start of administration. If you delay treatment, then by the time the medicine takes effect, the child’s body will already cope with the disease on its own. That is why this drug is often used for children as a prophylactic agent.

The medicine stimulates the production of late interferon and creates all the conditions for the production of cytokines. Small information molecules regulate intercellular and intersystem interactions, helping to more effectively fight viruses. Taking even one tablet increases the amount of interferon in the blood. At this point, the child’s body will be ready to face the virus.

Clinical studies have proven the effectiveness of Kagocel in the prevention of ARVI in children. The incidence rate decreased by 3 times.

It was also noted that children in contact with chickenpox carriers, after taking an antiviral drug, defeated the virus at the initial stage. In sick children, the symptoms of the disease were less pronounced, and they recovered much faster than their peers who did not take Kagocel.

The antiviral drug is often used as part of complex therapy for sore throats of streptococcal or staphylococcal etiology. Based on the studies, it was noted that in the vast majority of cases, the recovery process was shortened by 4-5 days, while the risk of complications was minimized.

Active substances, when taken in a course, do not accumulate in tissues and organs and are perfectly excreted from the body. Most (about 90%) is excreted naturally through the intestines, 10% is excreted by the kidneys.

Contraindications

Not in all cases, children can take Kagocel. This drug has a number of contraindications that must be familiarized with before starting treatment.

The medicine should not be used in the following conditions:

hypersensitivity to components;
pregnancy and lactation;
age up to 3 years.

If storage conditions are violated, or after the expiration date indicated on the packaging, the medication must be discarded. Concomitant use of the drug with other antiviral and immunomodulatory drugs is prohibited to avoid overdose. If you do not take into account the existing contraindications and violate the rules of administration, you may encounter severe side effects.

Instructions for use and dosage

Kagocel is available in a single form - tablets. Moreover, it is prescribed to both children over three years of age and adults, but in different dosages. Not a single pharmacy will offer Kagocel labeled “children’s”, because it does not exist. It is recommended to take the tablets after meals, but this does not affect the absorption of the medicine in the gastrointestinal tract.

Children over 12 years of age and adults with symptoms of ARVI and influenza should drink 2 tablets three times a day in the first 2 days, and one tablet three times a day on days 3-4. The duration of the course does not exceed four days. During this period, the patient must drink 18 tablets.
Children from 6 to 12 years old who are sick with ARVI and influenza should follow a similar dosage regimen: the first two days - 1 tablet three times a day, on days 3-4 - 1 tablet 2 times a day. Treatment lasts 4 days. In total, the child is given no more than 10 tablets.
Children from 3 to 6 years old who are infected with viral infections are prescribed: on days 1-2 – 1 tablet 2 times a day, on days 3-4 – 1 tablet 1 time a day. Course admission - 4 days. During this period, the little patient drinks 6 tablets.

To prevent infectious viral diseases, experts recommend cyclic use of Kagocel. Adults drink 2 tablets once a day in the first two days, then after 5 days the regimen is repeated.

Children are also prescribed 1 tablet every day. After two doses, a 5-day break is taken. The course can last from 1 week to several months. When treating other diseases (herpes, urogenital chlamydia, etc.), you should adhere to the following regimen: 2 tablets 3 times a day for 5 days.

Side effects, overdose

If you follow your doctor's recommendations and strictly follow the instructions for using Kagocel, the risk of side effects will be minimized. If negative reactions nevertheless develop after the patient has taken the pill, then the drug should be stopped. In this case, all unpleasant symptoms quickly disappear.

Side effects are extremely rare. However, a person may experience the following conditions:

allergic rhinitis;
rash and redness on the skin;
muscle weakness;
increased anxiety.

An overdose of the drug leads to a rapid deterioration in general health. The higher the dose, the more active the processes in the cells. Increased production of interferon can lead to the development of:

headaches;
nausea and vomiting;
pain in the abdomen and stomach;
liver dysfunction;
diarrhea, etc.

If a child exhibits one or more of the above symptoms of overdose, urgently seek medical help. Before the ambulance arrives, parents should help the child get rid of excess drug by inducing vomiting. The child needs to drink as much fluid as possible and take sorbents (Polysorb, activated carbon).

Drug analogues and cost

The cost of Kagocel varies between 200-250 rubles. The drug has many analogues with similar pharmacological effects. If for some reason Kagocel is not suitable, the following antiviral drugs can replace it:

Kagocel is a synthetic drug belonging to the group of immunostimulants and antiviral agents for systemic use.

Release form and composition

The medicine is produced in the form of biconvex tablets containing 12 mg of the active substance of the same name.

Excipients used in the production of Kagocel are calcium stearate, potato starch and ludipress (in other words, direct-pressed lactose) containing lactose monohydrate, crospovidone and povidone (kollidon 30).

Pharmacological properties of Kagocel

Kagocel is a drug created on the basis of new developments and pharmacological nanotechnologies due to the fact that microbiologists and epidemiologists managed to combine a molecule of a medicinal substance (and, importantly, of plant origin) with a nanopolymer. This synthesis significantly increased the effectiveness of the drug.

According to the instructions, Kagocel has a complex effect on the human body: antiviral, immunostimulating, antimicrobial and radioprotective.

The main mechanism of action of the drug is its ability to induce and enhance the production of interferon (a natural protein secreted by the body in response to viral invasion) in almost all cells involved in the antiviral response: endothelial cells, macrophages, fibroblasts, granulocytes, T- and B-lymphocytes . In this case, the drug promotes the formation of so-called late interferon, which is a mixture of α- and β-interferons that have the highest antiviral activity.

Pharmacokinetics

When one dose is taken orally (which is usually 2 tablets), the interferon titer reaches its maximum concentration in the blood serum after 48 hours, but in the intestines its peak value is observed after 4 hours.

As for the body’s interferon response, it is characterized by a fairly long (up to 5 days) circulation of the protein in the bloodstream.

When Kagocel is used in therapeutic doses, it has no toxic effects, does not accumulate in the body, and does not have teratogenic, mutagenic or embryotoxic properties.

The greatest effectiveness of Kagocel, according to reviews, is achieved when taking the drug no later than the fourth day after the onset of symptoms of acute infection.

In order to prevent a viral disease, the medication can be used at any time, optimally as soon as possible after direct contact with a sick person.

Kagocel's analogs

As for the active substance, structural analogues of Kagocel are not produced.

According to their belonging to the same pharmacological group, analogues of the drug are: Altabor, Amizon, Amizonchik, Arbidol, Armenicum, Arpeflu, Groprinosin, Isoprinosin, Imusstat, Novirin, Panavir, Flavozid, Erebra and others.

Indications for use

As stated in the instructions for Kagocel, the drug is intended for:

Prevention and treatment of influenza and acute respiratory viral infections in adults and children over 6 years of age;
Treatment of influenza and ARVI in children over 3 years of age;
For the treatment of herpes virus in adults;
For the treatment of urogenital chlamydia in adults (as part of complex therapy).

Contraindications to the use of Kagocel

Even if there are indications, Kagocel is not prescribed:

In case of increased individual sensitivity to the active or any of the auxiliary components of the drug;
Pregnant and breastfeeding women;
Children under 3 years old;
With diagnosed lactase deficiency, lactose intolerance or glucose-galactose malabsorption syndrome.

Directions for use and dosage

If the indication for Kagocel is viral infections or influenza, the following regimen is recommended for medicinal purposes for adults: course - 4 days, total number of tablets - 18, which are taken as follows: the first two days, 2 tablets. (loading dose) three times a day, the next two days, 1 tablet. also three times a day.

In order to prevent viral diseases and influenza in adults, the drug is taken in 7-day cycles: the first two days, 2 tablets at a time once a day, then a five-day break, after which the described scheme is repeated. The duration of the preventive course of Kagocel can be one week or several months.

For the treatment of children 3-6 years old, the following scheme is provided: course - 4 days, total number of tablets - 6 pieces, which should be taken as follows: the first two days, 1 tablet twice a day, then for another two days, 1 tablet. once a day.

When treating children over 6 years old, the following scheme is used: the course of treatment is 4 days, the total number of tablets is 10, which should be taken as follows: the first two days, 1 tablet. three times a day (loading dose), after which the next two days take 1 tablet. morning and evening (the interval between doses is 12 hours).

In order to prevent viral diseases and influenza in children over 6 years of age, Kagocel, according to the instructions, is taken in 7-day cycles: the first two days, 1 tablet once a day, then a five-day break, then the described scheme is repeated. The duration of such a course is at least 1 week, but can last for several months.

For the treatment of herpes virus and complex therapy of urogenital chlamydia, adults are prescribed to take 2 tablets three times a day for 5 days.

Side effects of Kagocel

As they say in reviews of Kagocel, the drug is well tolerated in more than 95% of cases. In extremely rare cases, allergic reactions occur due to intolerance to individual components.

Additional information

When using Kagocel, it should be borne in mind that when it is taken simultaneously with antibiotics, immunomodulators and other antiviral agents, an additive effect is observed (i.e., enhancing the effect of each other).

The medicine is dispensed from pharmacies without a doctor's prescription. Its shelf life is 24 months.